» Articles » PMID: 17503336

Intragenic Cis and Trans Modification of Genetic Susceptibility in DYT1 Torsion Dystonia

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2007 May 16
PMID 17503336
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

A GAG deletion in the DYT1 gene is a major cause of early-onset dystonia, but clinical disease expression occurs in only 30% of mutation carriers. To gain insight into genetic factors that may influence penetrance, we evaluated three DYT1 single-nucleotide polymorphisms, including D216H, a coding-sequence variation that moderates the effects of the DYT1 GAG deletion in cellular models. We tested DYT1 GAG-deletion carriers with (n=119) and without (n=113) clinical signs of dystonia and control individuals (n=197) and found the frequency of the 216H allele to be increased in GAG-deletion carriers without dystonia and to be decreased in carriers with dystonia, compared with the control individuals. Analysis of haplotypes demonstrated a highly protective effect of the H allele in trans with the GAG deletion; there was also suggestive evidence that the D216 allele in cis is required for the disease to be penetrant. Our findings establish, for the first time, a clinically relevant gene modifier of DYT1.

Citing Articles

Dissecting the Reduced Penetrance of Putative Loss-of-Function Variants in Population-Scale Biobanks.

Blair D, Risch N medRxiv. 2024; .

PMID: 39399029 PMC: 11469360. DOI: 10.1101/2024.09.23.24314008.


Clinical relevance and translational impact of reduced penetrance in genetic movement disorders.

Heinzel S, Mascalzoni D, Baumer T, Berg D, Kasten M, Bruggemann N Med Genet. 2024; 34(2):151-156.

PMID: 38835915 PMC: 11006340. DOI: 10.1515/medgen-2022-2128.


Patient-derived cells - an irreplaceable tool for research of reduced penetrance in movement disorders.

Seibler P, Rakovic A Med Genet. 2024; 34(2):125-130.

PMID: 38835901 PMC: 11006347. DOI: 10.1515/medgen-2022-2133.


Motor deficit and lack of overt dystonia in Dlx conditional Dyt1 knockout mice.

Berryman D, Barrett J, Liu C, Maugee C, Waldbaum J, Yi D Behav Brain Res. 2022; 439:114221.

PMID: 36417958 PMC: 10364669. DOI: 10.1016/j.bbr.2022.114221.


Dystonia Diagnosis: Clinical Neurophysiology and Genetics.

di Biase L, Di Santo A, Caminiti M, Pecoraro P, Carbone S, Di Lazzaro V J Clin Med. 2022; 11(14).

PMID: 35887948 PMC: 9320296. DOI: 10.3390/jcm11144184.


References
1.
Gambarin M, Valente E, Liberini P, Barrano G, Bonizzato A, Padovani A . Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia. Mov Disord. 2006; 21(10):1782-4. DOI: 10.1002/mds.21056. View

2.
Goodchild R, Dauer W . Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A. 2004; 101(3):847-52. PMC: 321769. DOI: 10.1073/pnas.0304375101. View

3.
Geyer H, Bressman S . The diagnosis of dystonia. Lancet Neurol. 2006; 5(9):780-90. DOI: 10.1016/S1474-4422(06)70547-6. View

4.
Svenson I, Kloos M, Gaskell P, Nance M, Garbern J, Hisanaga S . Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics. 2004; 5(3):157-64. DOI: 10.1007/s10048-004-0186-z. View

5.
Naismith T, Heuser J, Breakefield X, Hanson P . TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A. 2004; 101(20):7612-7. PMC: 419654. DOI: 10.1073/pnas.0308760101. View